SOURCE: Sunwin International Neutraceuticals, Inc.

May 03, 2006 08:30 ET

Sunwin International Neutraceuticals Forms a Canadian Subsidiary to Distribute Chinese Herb-Based Medicines

QUFU, CHINA -- (MARKET WIRE) -- May 3, 2006 -- Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN), an industry leader in the production and distribution of Chinese herbs, veterinary medicines and low calorie natural sweetener (Stevia) in China, has formed a wholly owned subsidiary in Canada, Sunwin (Canada) Pharmaceuticals, Limited, in order to market its Chinese herb-based medicines throughout Canada. These Chinese herbs include Hypericin, Honeysuckle, Angelica, Chrysanthemum, Epimedium, and Dandelion. The newly formed subsidiary will submit applications to Health Canada for product licenses and site licenses in order to distribute our products in Canada.

Mr. Laiwang Zhang, President and Chairman of Sunwin International, commented, "We are excited about the market potential for our products in Canada. We believe that the Canadian distribution of our products can bring substantial profits to the company, as we continue to integrate our manufacturing, production and distribution. We are contracting marketing professionals to guide our operations in Canada. We believe there are tremendous needs for our products in Canadian market places."

In addition, Sunwin announced today its management will attend the World Money Show, May 15-18, 2006 at Paris/Bally's Resort, 3655 Las Vegas Blvd, Las Vegas. It is expected over 8,800 individual and institutional investors will attend this four-day event. SUWN will present in a workshop entitled "Growth of China," sponsored by China Direct Investments, Inc. at 2:15 pm, Tuesday, May 15, 2006. Furthermore, Sunwin will be hosting a series of one-on-one meetings and investor luncheons in Las Vegas.

All shareholders and prospective investors are welcome to attend. Please RSVP to Those interested in arranging one-to-one meetings with the management of Sunwin, please coordinate with Jim Glickstein at 1-877-CHINA-57.

About Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, low-calorie natural sweetener (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumers to provide a quality and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of the China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received an award as one of Shandong's Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more info about Sunwin, please visit

Safe Harbor Statement

Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.

Contact Information